BioCentury | Feb 28, 2017
Distillery Therapeutics

Infectious disease

...progenitor cells. Next steps include structure-based optimization of the compound for increased US28 selectivity. TARGET/MARKER/PATHWAY: CMV CC chemokine receptor (US28)...
...Sinclair, same affiliation as above email: Hongjiang Li University of Cambridge Chemokine CX3C motif ligand 1 (CX3CL1) (Fractalkine) CMV CC chemokine receptor (US28) P...
BioCentury | Jul 23, 2015
Distillery Therapeutics

Therapeutics: CMV CC chemokine receptor (US28)

...include optimization of the fusion proteins and testing in additional models of HCMV infection. TARGET/MARKER/PATHWAY: CMV CC chemokine receptor (US28)...
BioCentury | Jan 17, 2011
Emerging Company Profile

Inagen: Defense creates offense

...any toxin could be used. Kledal said CMV-infected cells express viral-encoded chemokine receptors, such as CMV CC chemokine receptor (US28)...
Items per page:
1 - 3 of 3